Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Clin Cancer Res. 2009 Nov 24;15(23):7405–7411. doi: 10.1158/1078-0432.CCR-09-1502

Fig 1.

Fig 1

Patients received flavopiridol as a 1-hour infusion (t=0 hr), concurrently with oxaliplatin at a starting dose of 60 mg/m2, and leucovorin at 400 mg/m2 administered over two hours (t=0 hr). This was followed by 5-fluorouracil given as a bolus infusion starting at 400 mg/m2 (t=2 hr), and then a 48-hour continuous infusion at either 1800 or 2400 mg/m2 over 48 hours (t=2:15 hr).